Stockscreener 앱 받기
7.89
4.50%
0.34
Portage Biotech Inc 주식(PRTG)의 최신 뉴스
Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish - Asianet Newsable
Investing in Portage Biotech Inc (PRTG) Is Getting More Attractive - knoxdaily.com
Market Analysts see Portage Biotech Inc [PRTG] gaining to $26. Time to buy? - dbtnews.com
Portage Biotech (PRTG) Reports Promising Preclinical Results for PORT-7 | PRTG Stock News - GuruFocus
Insider Activity Signals Optimism for Portage Biotech (PRTG) - GuruFocus
Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish By Stocktwits - Investing.com India
Portage Biotech Reports Confirmatory Preclinical Results in Meso - GuruFocus
The Future of Portage Biotech Inc: Analyzing PRTG - investchronicle.com
How analysts predict Portage Biotech Inc (PRTG) will perform this quarter? - uspostnews.com
Portage Biotech Stock Surges As It Prepares For Human Trial - Benzinga
Portage Biotech stock soars on promising preclinical results By Investing.com - Investing.com Nigeria
Portage Biotech stock soars on promising preclinical results - Investing.com Australia
Portage Biotech’s PORT-7 shows efficacy in mesothelioma preclinical study - TipRanks
Top Premarket Gainers - marketscreener.com
Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma - TipRanks
Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - The Manila Times
New Cancer Breakthrough: PORT-7 Outperforms Standard Treatment in Mesothelioma Study - Stock Titan
Insider Stock Buying Reaches US$2.15m On Portage Biotech - Yahoo
Portage Biotech Inc (PRTG) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
PRTG Stock on the Rise: A Promising Investment - investchronicle.com
Short Interest in Portage Biotech Inc. (NASDAQ:PRTG) Rises By 2,134.8% - Defense World
SoftBank Group (OTCMKTS:SFTBF) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
iAnthus Capital Holdings, Inc. (OTCMKTS:ITHUF) Short Interest Up 2,600.0% in March - Defense World
Corning Natural Gas (OTCMKTS:CNIG) Shares Pass Below 200-Day Moving Average – Here’s What Happened - Defense World
Scorpio Gold (OTCMKTS:SRCRF) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Portage Biotech (PRTG) Resumes Key Clinical Trial Phase - GuruFocus
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Gains Over 50 Points; JPMorgan Posts Upbeat Earnings - Benzinga
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX - Yahoo Finance
CVS Health Corporation (CVS): A Bull Case Theory - Yahoo Finance
Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts - Yahoo Finance
ImmunityBio, Inc. (IBRX): Among Stocks Under $10 that Will Triple - Yahoo Finance
Cannara Biotech Inc.'s (CVE:LOVE) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors - Yahoo Finance
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer - Yahoo Finance
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Small Cap Stocks To Add to Your WatchlistMarch 29th - MarketBeat
Promising Biotech Stocks To Watch Now – March 28th - The AM Reporter
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - Asianet Newsable
Portage Biotech Insider Buyers See Boost After Market Cap Rose US$9.0m - simplywall.st
Portage Biotech (NASDAQ:PRTG) vs. Cytokinetics (NASDAQ:CYTK) Head-To-Head Survey - Defense World
Biotech Firms Celebrate Gains With Promising Trials And Partnerships - Finimize
Satellos Bioscience (TSE:MSCL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Why Is Portage Biotech Stock Skyrocketing Friday? - Benzinga
1.54%
7.58%
자본화:
|
볼륨(24시간):